Equities researchers at StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Dawson James began coverage on shares of Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a “buy” rating and a […]

Related Keywords

Zembrace Symtouch , Dawson James , Tonix Pharmaceuticals Company Profile , News Ratings For Tonix Pharmaceuticals Daily , Armistice Capital , Hedge Funds Weigh In On Tonix Pharmaceuticals , Sabby Management , Tonix Pharmaceuticals , Tonix Pharmaceuticals Holding Corp , Tonix Pharmaceuticals Price Performance , Acadian Asset Management , Get Free Report , Asset Management , Pharmaceuticals Holding Corp , Tonix Pharmaceuticals Daily ,